Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The heart pump devices market is witnessing remarkable growth driven by advances in cardiac care and technology. As cardiovascular diseases become more prevalent worldwide, the demand for innovative heart support devices is accelerating. This overview delves into the market’s current size, the main factors fueling its expansion, key segments, industry trends, and the leading players shaping its future.

Rapid Growth Forecast for the Heart Pump Devices Market

The heart pump devices market has shown substantial growth recently and is expected to continue on this trajectory. From a market size of $4.48 billion in 2025, it is projected to rise to $5.32 billion in 2026, marking a CAGR of 19.0%. Factors behind this historical growth include an increasing number of heart failure cases, the spread of cardiac surgery programs, innovations in mechanical pump designs, longer transplant waiting lists, and the expanding use of extracorporeal support systems. Looking ahead, the market is predicted to reach $10.37 billion by 2030 with a CAGR of 18.1%, supported by rising demand for long-term circulatory support, wider adoption of destination therapy devices, growth in minimally invasive cardiac procedures, enhanced integration of smart monitoring technologies, and increased investments in cutting-edge cardiac care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8766&type=smp

Primary Drivers Behind Heart Pump Devices Market Expansion

The growing incidence of cardiovascular diseases is a key factor propelling the heart pump devices market forward. Cardiovascular disorders encompass a range of conditions affecting the heart and blood vessels, which necessitate advanced treatment options such as heart pump devices. These devices assist in maintaining blood flow during critical interventions like high-risk percutaneous coronary procedures, boosting their demand. For example, the American Heart Association reported that the age-adjusted death rate from cardiovascular disease in the United States increased to 233.3 per 100,000 people in 2024, up 4.0% from 224.4 per 100,000 in 2023. This rising prevalence underscores the urgent need for innovative cardiac support solutions, thereby driving market growth.

Key Segments Defining Revenue Opportunities in the Heart Pump Devices Market

This market is segmented into three main categories:

1) By Type: Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices

2) By Therapy: Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT), and Other Therapies

3) By End-user: Hospitals, Cardiac Specialty Hospitals/Heart Centers, Transplant Centers, and Other End-Users

Further detail includes implantable devices such as Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BiVADs), and Total Artificial Hearts (TAHs). Extracorporeal heart pump devices cover Intra-Aortic Balloon Pumps (IABPs) and temporary Ventricular Assist Devices like centrifugal blood pumps.

Access The Complete Heart Pump Devices Market Report:

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Emerging Trends Influencing the Heart Pump Devices Market

Leading companies in the heart pump devices sector are increasingly focusing on extracorporeal membrane oxygenation (ECMO) technology to offer advanced life support for patients with severe cardiac and pulmonary failure. ECMO systems provide prolonged mechanical assistance by taking over the functions of the heart and lungs, which is critical in life-threatening situations. For instance, in September 2024, Medtronic plc introduced the VitalFlow system, an innovative ECMO solution combining a pump and oxygenator to support circulation in patients with serious heart or lung conditions. This technology enables vital organ rest and recovery, marking a significant advancement in the field.

Prominent Companies Driving Innovation in the Heart Pump Devices Market

The heart pump devices market includes several influential players shaping its development, such as Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova plc, SynCardia Systems Inc, CARMAT SA, Jarvik Heart Inc, BiVACOR Inc, CorWave SA, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Nipro Corporation, Eurosets Srl, CardioBridge GmbH, Hemovent GmbH, Evaheart Inc, Calon Cardio-Technology Ltd, Lepu Medical Technology Co Ltd, and NewHeart Technologies Inc. These companies are at the forefront of research, development, and commercialization of advanced cardiac support devices.

North America Leading the Heart Pump Devices Market Share

In 2025, North America held the largest portion of the heart pump devices market. The market report also covers other key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market distribution and growth patterns.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model